相关期刊:《Asian Journal of Pharmaceutical Sciences》《中国医药工业杂志》《International Journal of Ophthalmology(English edition)》《Chemical Research in Chinese Universities》更多>>
Supported by Golestan University of Medical Sciences(No.111294).
AIM:To evaluate the effect of auraptene(AUR)treatment in forms of free and encapsulated in niosome nanoparticles by investigating the mRNA expression level of vascular endothelium growth factor(VEGF)-A and platelet-de...
Supported by Stem Cell Research Center of Golestan University of Medical Sciences(No.110480).
AIM:To investigate the impact of niosome nanoparticles carrying umbelliprenin(UMB),an anti-angiogenic and anti-inflammatory plant compound,on the expression of vascular endothelial growth factor(VEGF-A)and connective ...
In the last few decades numbers of review and research articles have been published on niosomes. This shows the relevant interest of academias & researchers in niosomes because of the advantages sponsored by them over...
financially supported by the Iran National Science Foundation under Grant ID 95839151 to Saeedeh Farajzadeh
Objective: To explore the antileishmanial effect of tioxolone and its niosomal form against Leishmania tropica. Methods: Tioxolone niosomes were prepared by the hydration method and were evaluated for morphology, size...
Tocotrienol(T3),the unsaturated form of vitamin E,has gained global attention due to its potent anticancer effects against a wide range of cancers.Found abundantly in palm oil[1],T3was reported to exhibit their anti-c...
Supported by the National Natural Science Foundation of China(No.20573091), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions of China and the Postgraduate Scientific Research and Innovation Projects of Jiangsu Province, China(No. CXLX 11-0995).
Hollow polypyrrole nanospheres were successfully prepared in a Span80/PEG400/H20(PEG=polyethylene glycol) niosome system. The formation and morphology of the nanospheres vary with the concentrations of pyrrole monom...